Wolverine Trading, LLC Agenus Inc Put Options Transaction History

Wolverine Trading, LLC

17 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 15, 2023	BUY	$1.45 - $2.95 $16,965 - $34,515	11,700 New	11,700 $17,000
Q1 2022 May 16, 2022	BUY	$2.35 - $3.47 $56,165 - $82,933	23,900 New	23,900 $63,000
Q4 2021 Feb 14, 2022	SELL	$2.92 - $5.74 $130,816 - $257,152	-44,800 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$4.98 - $6.63 $223,104 - $297,024	44,800 New	44,800 $235,000
Q2 2021 Aug 06, 2021	SELL	$2.56 - $5.49 $38,912 - $83,448	-15,200 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$2.69 - $5.25 $5,380 - $10,500	-2,000 Reduced 11.63%	15,200 $41,000
Q2 2020 Aug 13, 2020	SELL	$2.29 - $4.24 $5,725 - $10,600	-2,500 Reduced 12.69%	17,200 $68,000
Q1 2020 May 11, 2020	SELL	$1.92 - $4.39 $17,280 - $39,510	-9,000 Reduced 31.36%	19,700 $47,000
Q4 2019 Feb 12, 2020	BUY	$2.41 - $4.4 $34,704 - $63,360	14,400 Added 100.7%	28,700 $115,000
Q3 2019 Nov 14, 2019	SELL	$2.17 - $3.14 $3,038 - $4,396	-1,400 Reduced 8.92%	14,300 $38,000
Q2 2019 Aug 20, 2019	SELL	$2.53 - $3.04 $23,023 - $27,664	-9,100 Reduced 36.69%	15,700 $47,000
Q1 2019 May 15, 2019	BUY	$2.51 - $3.73 $4,267 - $6,341	1,700 Added 7.36%	24,800 $74,000
Q4 2018 Feb 14, 2019	BUY	$1.59 - $2.66 $15,105 - $25,270	9,500 Added 69.85%	23,100 $55,000
Q3 2018 Nov 14, 2018	SELL	$1.59 - $2.42 $24,168 - $36,784	-15,200 Reduced 52.78%	13,600 $29,000
Q1 2018 May 15, 2018	BUY	$3.51 - $6.04 $50,895 - $87,580	14,500 Added 101.4%	28,800 $136,000
Q4 2017 Feb 14, 2018	SELL	$3.26 - $4.78 $3,911 - $5,736	-1,200 Reduced 7.74%	14,300 $47,000
Q3 2017 Nov 15, 2017	BUY	$3.48 - $4.44 $53,940 - $68,820	15,500	15,500 $68,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.